Lagarde expected to clarify ECB bond-buying plans
ECB has lowered purchases as yields have risen and spreads have increased
European Central Bank president Christine Lagarde is expected to provide more clarity on the institution’s bond purchase plans after the policy meeting on March 11.
Observers have become increasingly confused over the central bank’s actions and communication over the past few weeks. As sovereign bond yields have increased, the ECB has maintained bond purchases under the Pandemic Emergency Purchase Programme (Pepp) at the lowest level since it was launched almost a year ago.
Ahead of the policy
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact info@centralbanking.com or view our subscription options here: http://subscriptions.centralbanking.com/subscribe
You are currently unable to print this content. Please contact info@centralbanking.com to find out more.
You are currently unable to copy this content. Please contact info@centralbanking.com to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@centralbanking.com
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email info@centralbanking.com
Most read
- Supervisors grapple with the smaller bank dilemma
- Central bank of the year: Central Bank of Brazil
- Fed policy-makers disagree over risks